Generation of a novel attenuated IBDV vaccine strain by mutation of critical amino acids in IBDV VP5.

Autor: Gao H; National Key Laboratory of Veterinary Public Health Security, Beijing 100193, China; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, Beijing 100193, China; College of Veterinary Medicine, China Agricultural University, Beijing 100193, China., Zhang S; National Key Laboratory of Veterinary Public Health Security, Beijing 100193, China; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, Beijing 100193, China; College of Veterinary Medicine, China Agricultural University, Beijing 100193, China., Chang H; National Key Laboratory of Veterinary Public Health Security, Beijing 100193, China; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, Beijing 100193, China; College of Veterinary Medicine, China Agricultural University, Beijing 100193, China., Guo Y; National Key Laboratory of Veterinary Public Health Security, Beijing 100193, China; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, Beijing 100193, China; College of Veterinary Medicine, China Agricultural University, Beijing 100193, China., Li Z; National Key Laboratory of Veterinary Public Health Security, Beijing 100193, China; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, Beijing 100193, China; College of Veterinary Medicine, China Agricultural University, Beijing 100193, China., Wang Y; National Key Laboratory of Veterinary Public Health Security, Beijing 100193, China; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, Beijing 100193, China; College of Veterinary Medicine, China Agricultural University, Beijing 100193, China., Gao L; National Key Laboratory of Veterinary Public Health Security, Beijing 100193, China; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, Beijing 100193, China; College of Veterinary Medicine, China Agricultural University, Beijing 100193, China., Li X; National Key Laboratory of Veterinary Public Health Security, Beijing 100193, China; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, Beijing 100193, China; College of Veterinary Medicine, China Agricultural University, Beijing 100193, China., Cao H; National Key Laboratory of Veterinary Public Health Security, Beijing 100193, China; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, Beijing 100193, China; College of Veterinary Medicine, China Agricultural University, Beijing 100193, China., Zheng SJ; National Key Laboratory of Veterinary Public Health Security, Beijing 100193, China; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, Beijing 100193, China; College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. Electronic address: sjzheng@cau.edu.cn.
Jazyk: angličtina
Zdroj: Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126081. Date of Electronic Publication: 2024 Jun 29.
DOI: 10.1016/j.vaccine.2024.06.048
Abstrakt: Infectious bursal disease virus (IBDV) is an acute and highly infectious RNA virus known for its immunosuppressive capabilities, chiefly inflicting rapid damage to the bursa of Fabricius (BF) of chickens. Current clinical control of IBDV infection relies on vaccination. However, the emergence of novel variant IBDV (nVarIBDV) has posed a threat to the poultry industry across the globe, underscoring the great demand for innovative and effective vaccines. Our previous studies have highlighted the critical role of IBDV VP5 as an apoptosis-inducer in host cells. In this study, we engineered IBDV mutants via a reverse genetic system to introduce amino acid mutations in VP5. We found that the mutant IBDV-VP5/3m strain caused reduced host cell mortality, and that strategic mutations in VP5 reduced IBDV replication early after infection, thereby delaying cell death. Furthermore, inoculation of chickens with IBDV-VP5/3m effectively reduced damage to BF and induced neutralizing antibody production comparable to that of parental IBDV WT strain. Importantly, vaccination with IBDV-VP5/3m protected chickens against challenges with nVarIBDV, an emerging IBDV variant strain in China, reducing nVarIBDV loads in BF while alleviating bursal atrophy and splenomegaly, suggesting that IBDV-VP5/3m might serve as a novel vaccine candidate that could be further developed as an effective vaccine for clinical control of IBD. This study provides a new clue to the development of novel and effective vaccines.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: